GlaxoSmithKline Bangladesh Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was BDT 4,474.898 million compared to BDT 4,816.557 million a year ago. Operating income was BDT 1,144.536 million compared to BDT 1,183.205 million a year ago. Net income was BDT 808.062 million compared to net loss of BDT 521.094 million a year ago.